Cases of Rapid Hepatitis B Surface Antigen Reduction after COVID-19 Vaccination

OBJECTIVE: One of the therapeutic goals for chronic infection with hepatitis B virus is the clearance of hepatitis B surface antigen (HBsAg) from the blood, as a high load of HBsAg has been proposed to induce antigen-specific immunotolerance. To achieve HBsAg reduction, Pegylated interferon and nucl...

Descripción completa

Detalles Bibliográficos
Autores principales: Osawa, Yosuke, Ohtake, Takaaki, Suto, Daisuke, Akita, Takayuki, Yamada, Hidehiko, Kohgo, Yutaka, Murata, Kazumoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9876716/
https://www.ncbi.nlm.nih.gov/pubmed/36261382
http://dx.doi.org/10.2169/internalmedicine.0842-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9876716/
https://www.ncbi.nlm.nih.gov/pubmed/36261382
http://dx.doi.org/10.2169/internalmedicine.0842-22

Ejemplares similares